LAURA WAVRA: Open Payments
NPI 1003876434 · WEST LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 98 payments from 13 companies in 2025. Trend: 2023 $1,207 · 2024 $1,367 · 2025 $1,478
Food & beverage: $1,284Education: $194
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $310 |
| ABBVIE INC. | 20 | $240 |
| Regeneron Healthcare Solutions, Inc. | 12 | $228 |
| Galderma Laboratories, L.P. | 14 | $216 |
| Janssen Biotech, Inc. | 12 | $202 |
| UCB, Inc. | 3 | $72 |
| Amgen Inc. | 2 | $46 |
| PFIZER INC. | 2 | $34 |
| LEO Pharma Inc. | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
Products named: DUPIXENT, NEMLUVIO, TREMFYA, RINVOQ, SKYRIZI, COSENTYX, Bimzelx, OTEZLA.
Industry payments across IN — which companies pay providers there.
